Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 0.02
COO's Cash to Debt is ranked lower than
56% of the 288 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.07 vs. COO: 0.02 )
COO' s 10-Year Cash to Debt Range
Min: 0   Max: 1.92
Current: 0.02

0
1.92
Equity to Asset 0.58
COO's Equity to Asset is ranked higher than
68% of the 282 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.59 vs. COO: 0.58 )
COO' s 10-Year Equity to Asset Range
Min: -0.02   Max: 0.77
Current: 0.58

-0.02
0.77
Interest Coverage 38.48
COO's Interest Coverage is ranked higher than
73% of the 182 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 32.42 vs. COO: 38.48 )
COO' s 10-Year Interest Coverage Range
Min: 1.07   Max: 38.48
Current: 38.48

1.07
38.48
F-Score: 5
Z-Score: 3.20
M-Score: -2.53
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 17.84
COO's Operating margin (%) is ranked higher than
88% of the 287 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.64 vs. COO: 17.84 )
COO' s 10-Year Operating margin (%) Range
Min: 4.82   Max: 23.82
Current: 17.84

4.82
23.82
Net-margin (%) 15.71
COO's Net-margin (%) is ranked higher than
91% of the 287 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.99 vs. COO: 15.71 )
COO' s 10-Year Net-margin (%) Range
Min: -1.18   Max: 34.8
Current: 15.71

-1.18
34.8
ROE (%) 10.70
COO's ROE (%) is ranked higher than
79% of the 278 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.72 vs. COO: 10.70 )
COO' s 10-Year ROE (%) Range
Min: -0.79   Max: 244.12
Current: 10.7

-0.79
244.12
ROA (%) 7.80
COO's ROA (%) is ranked higher than
84% of the 289 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.08 vs. COO: 7.80 )
COO' s 10-Year ROA (%) Range
Min: -0.45   Max: 22.6
Current: 7.8

-0.45
22.6
ROC (Joel Greenblatt) (%) 24.34
COO's ROC (Joel Greenblatt) (%) is ranked higher than
80% of the 288 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 20.54 vs. COO: 24.34 )
COO' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 5.7   Max: 75.46
Current: 24.34

5.7
75.46
Revenue Growth (3Y)(%) 8.40
COO's Revenue Growth (3Y)(%) is ranked higher than
81% of the 262 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.50 vs. COO: 8.40 )
COO' s 10-Year Revenue Growth (3Y)(%) Range
Min: 4.8   Max: 27.8
Current: 8.4

4.8
27.8
EBITDA Growth (3Y)(%) 2.90
COO's EBITDA Growth (3Y)(%) is ranked higher than
71% of the 221 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.30 vs. COO: 2.90 )
COO' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -8.6   Max: 62.2
Current: 2.9

-8.6
62.2
EPS Growth (3Y)(%) 14.90
COO's EPS Growth (3Y)(%) is ranked higher than
83% of the 220 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.20 vs. COO: 14.90 )
COO' s 10-Year EPS Growth (3Y)(%) Range
Min: -15.2   Max: 474.9
Current: 14.9

-15.2
474.9
» COO's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q4 2013

COO Guru Trades in Q4 2013

Bill Frels 3,000 sh (New)
Chuck Royce 3,800 sh (+660%)
Steven Cohen 15,338 sh (+376.63%)
Jim Simons 129,498 sh (+309.8%)
RS Investment Management Sold Out
Mario Gabelli 30,500 sh (-11.59%)
Ken Fisher 53,850 sh (-14.05%)
Paul Tudor Jones 3,406 sh (-18.9%)
» More
Q1 2014

COO Guru Trades in Q1 2014

Ron Baron 245,624 sh (New)
Manning & Napier Advisors, Inc 97,210 sh (New)
Steven Cohen 115,186 sh (+650.98%)
Paul Tudor Jones 5,907 sh (+73.43%)
Chuck Royce 3,800 sh (unchged)
Bill Frels Sold Out
Jim Simons Sold Out
Mario Gabelli 30,000 sh (-1.64%)
Ken Fisher 51,050 sh (-5.2%)
» More
Q2 2014

COO Guru Trades in Q2 2014

Mario Gabelli 49,586 sh (+65.29%)
Ron Baron 356,783 sh (+45.26%)
Manning & Napier Advisors, Inc 116,400 sh (+19.74%)
Steven Cohen 217,800 sh (unchged)
Ken Fisher 49,609 sh (-2.82%)
Chuck Royce 3,100 sh (-18.42%)
Paul Tudor Jones 4,800 sh (-18.74%)
» More
Q3 2014

COO Guru Trades in Q3 2014

Paul Tudor Jones 5,800 sh (+20.83%)
Ken Fisher 56,294 sh (+13.48%)
Manning & Napier Advisors, Inc Sold Out
Steven Cohen Sold Out
Ron Baron 356,193 sh (-0.17%)
Chuck Royce 2,200 sh (-29.03%)
Mario Gabelli 27,200 sh (-45.15%)
» More
» Details

Insider Trades

Latest Guru Trades with COO

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Mario Gabelli 2014-09-30 Reduce -45.15%0.02%$144.66 - $164.29 $ 162.873%27200
Ron Baron 2014-06-30 Add 45.26%0.06%$123.62 - $138.37 $ 162.8723%356783
Mario Gabelli 2014-06-30 Add 65.29%0.01%$123.62 - $138.37 $ 162.8723%49586
Ron Baron 2014-03-31 New Buy0.14%$117.3 - $138.58 $ 162.8727%245624
Ken Fisher 2013-03-31 Add 33.17%$92.48 - $108.23 $ 162.8760%55000
Ray Dalio 2012-12-31 Sold Out 0.02%$89.4 - $100.67 $ 162.8771%0
Ken Fisher 2012-12-31 Add 142.94%0.01%$89.4 - $100.67 $ 162.8771%41300
Steve Mandel 2012-09-30 Sold Out 0.95%$72.45 - $94.83 $ 162.8799%0
Ray Dalio 2012-09-30 New Buy0.02%$72.45 - $94.83 $ 162.8799%14658
Steve Mandel 2012-06-30 New Buy0.95%$76.63 - $88.45 $ 162.8795%2017657
Ken Fisher 2012-06-30 New Buy$76.63 - $88.45 $ 162.8795%17012
Richard Perry 2012-03-31 Sold Out 0.44%$68.74 - $81.96 $ 162.87132%0
Joel Greenblatt 2012-03-31 Sold Out 0.04%$68.74 - $81.96 $ 162.87132%0
Mario Gabelli 2012-03-31 Reduce -25.25%0.01%$68.74 - $81.96 $ 162.87132%75500
Richard Perry 2011-12-31 New Buy0.44%$56.64 - $78.59 $ 162.87142%100000
Ray Dalio 2011-12-31 Sold Out 0.13%$56.64 - $78.59 $ 162.87142%0
Joel Greenblatt 2011-12-31 New Buy0.04%$56.64 - $78.59 $ 162.87142%4189
Ray Dalio 2011-09-30 Add 38.62%0.04%$63.8 - $83 $ 162.87115%108244
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Guru Investment Theses on Cooper Companies

Baron Funds Comments on The Cooper Companies - May 02, 2014

We established a position in The Cooper Companies, Inc. (COO) during the quarter. Cooper's primary business is manufacturing contact lenses, and it also has a relatively small unit focused on women's health products. There are several characteristics of the contact lens market that we find attractive. There are just four global players that account for the large bulk of the industry's sales, barriers to entry are high, and pricing trends are stable. The industry has grown at a mid-single digit rate for the past several years, and we believe that several developments should cause this growth rate to accelerate going forward. These include the widespread adoption of Silicon Hydrogel lenses, which provide a more comfortable user experience; recent technological advances that have led to lenses that can address a wider variety of vision deficiencies; the increasing conversion of bi-weekly contact users to daily-use lenses (which results in higher revenues for the manufacturer); and, the ongoing growth of the middle classes in emerging markets, which allows new entrants into the contact market.



Cooper is the third largest lens manufacturer with approximately 20% market share. The company has grown its share in recent years by introducing technologically superior products, particularly in the fast- growing Silicon Hydrogel market segment. We believe that Cooper can continue to grow at an above-market rate by further penetrating the global market with its superior products and by converting existing users from bi- weekly to daily contacts. In addition, we believe that Cooper should be able to expand its operating margins at a faster rate than revenues, as its Silicon Hydrogel lenses carry meaningfully higher gross margins than its legacy products, and sales growth will allow the company to leverage its fixed overheard. We believe Cooper will be able to grow its earnings per share at a high-teens rate for the next several years.



From Baron Funds' first quarter 2014 letter to investors.



Check out Ron Baron latest stock trades

Top Ranked Articles about Cooper Companies

Baron Funds Comments on The Cooper Companies
We established a position in The Cooper Companies, Inc. (COO) during the quarter. Cooper's primary business is manufacturing contact lenses, and it also has a relatively small unit focused on women's health products. There are several characteristics of the contact lens market that we find attractive. There are just four global players that account for the large bulk of the industry's sales, barriers to entry are high, and pricing trends are stable. The industry has grown at a mid-single digit rate for the past several years, and we believe that several developments should cause this growth rate to accelerate going forward. These include the widespread adoption of Silicon Hydrogel lenses, which provide a more comfortable user experience; recent technological advances that have led to lenses that can address a wider variety of vision deficiencies; the increasing conversion of bi-weekly contact users to daily-use lenses (which results in higher revenues for the manufacturer); and, the ongoing growth of the middle classes in emerging markets, which allows new entrants into the contact market. Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 29.50
COO's P/E(ttm) is ranked higher than
81% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 42.00 vs. COO: 29.50 )
COO' s 10-Year P/E(ttm) Range
Min: 7.98   Max: 1011.75
Current: 29.5

7.98
1011.75
P/B 3.06
COO's P/B is ranked higher than
73% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.38 vs. COO: 3.06 )
COO' s 10-Year P/B Range
Min: 0.37   Max: 4.45
Current: 3.06

0.37
4.45
P/S 4.82
COO's P/S is ranked higher than
60% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.74 vs. COO: 4.82 )
COO' s 10-Year P/S Range
Min: 0.51   Max: 5.98
Current: 4.82

0.51
5.98
PFCF 63.87
COO's PFCF is ranked higher than
75% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 57.37 vs. COO: 63.87 )
COO' s 10-Year PFCF Range
Min: 7.34   Max: 342.65
Current: 63.87

7.34
342.65
EV-to-EBIT 30.15
COO's EV-to-EBIT is ranked higher than
74% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 29.42 vs. COO: 30.15 )
COO' s 10-Year EV-to-EBIT Range
Min: 8.2   Max: 68.2
Current: 30.15

8.2
68.2
PEG 3.47
COO's PEG is ranked higher than
88% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9999.00 vs. COO: 3.47 )
COO' s 10-Year PEG Range
Min: 0.74   Max: 31.7
Current: 3.47

0.74
31.7
Shiller P/E 38.17
COO's Shiller P/E is ranked higher than
83% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 139.22 vs. COO: 38.17 )
COO' s 10-Year Shiller P/E Range
Min: 6.7   Max: 49.67
Current: 38.17

6.7
49.67
Current Ratio 1.79
COO's Current Ratio is ranked higher than
59% of the 282 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.72 vs. COO: 1.79 )
COO' s 10-Year Current Ratio Range
Min: 1.04   Max: 3.46
Current: 1.79

1.04
3.46
Quick Ratio 0.93
COO's Quick Ratio is ranked higher than
51% of the 282 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.85 vs. COO: 0.93 )
COO' s 10-Year Quick Ratio Range
Min: 0.8   Max: 2.95
Current: 0.93

0.8
2.95

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.04
COO's Dividend Yield is ranked lower than
95% of the 150 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.46 vs. COO: 0.04 )
COO' s 10-Year Dividend Yield Range
Min: 0.04   Max: 0.52
Current: 0.04

0.04
0.52
Dividend Payout 0.01
COO's Dividend Payout is ranked higher than
100% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9999.00 vs. COO: 0.01 )
COO' s 10-Year Dividend Payout Range
Min: 0.01   Max: 0.04
Current: 0.01

0.01
0.04
Yield on cost (5-Year) 0.10
COO's Yield on cost (5-Year) is ranked lower than
90% of the 153 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.71 vs. COO: 0.10 )
COO' s 10-Year Yield on cost (5-Year) Range
Min: 0.04   Max: 0.33
Current: 0.1

0.04
0.33
Share Buyback Rate -0.40
COO's Share Buyback Rate is ranked higher than
83% of the 235 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -2.30 vs. COO: -0.40 )
COO' s 10-Year Share Buyback Rate Range
Min: 1.5   Max: -13
Current: -0.4

Valuation & Return

vs
industry
vs
history
Price/DCF (Projected) 1.81
COO's Price/DCF (Projected) is ranked higher than
82% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.64 vs. COO: 1.81 )
COO' s 10-Year Price/DCF (Projected) Range
Min: 0.55   Max: 4
Current: 1.81

0.55
4
Price/Median PS Value 1.63
COO's Price/Median PS Value is ranked higher than
59% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.19 vs. COO: 1.63 )
COO' s 10-Year Price/Median PS Value Range
Min: 0.26   Max: 1.83
Current: 1.63

0.26
1.83
Price/Peter Lynch Fair Value 2.33
COO's Price/Peter Lynch Fair Value is ranked higher than
92% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9999.00 vs. COO: 2.33 )
COO' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.68   Max: 3.57
Current: 2.33

0.68
3.57
Earnings Yield (Greenblatt) 3.30
COO's Earnings Yield (Greenblatt) is ranked higher than
73% of the 285 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.50 vs. COO: 3.30 )
COO' s 10-Year Earnings Yield (Greenblatt) Range
Min: 1.5   Max: 12.2
Current: 3.3

1.5
12.2
Forward Rate of Return (Yacktman) 15.20
COO's Forward Rate of Return (Yacktman) is ranked higher than
84% of the 168 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 10.33 vs. COO: 15.20 )
COO' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -2.4   Max: 30.3
Current: 15.2

-2.4
30.3

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, ISRG » details
Traded in other countries:CP6.Germany, COO.Mexico,
Cooper Companies is a Delaware corporation organized in 1980. The Company is a medical device company. The Company operates through two business units: CooperVision, Inc. and CooperSurgical, Inc. They compete on the basis of product quality and differentiation, technological benefit, service and reliability. CooperVision is engaged in the manufacture and sale of products for contact lens wearers. CooperVision develops, manufactures and markets monthly, two-week and single-use contact lenses, including advanced materials and optics. The contact lens market has two major product categories namely Spherical lenses including lenses that correct near- and farsightedness uncomplicated by more complex visual defects; and toric and multifocal lenses including lenses that address more complex visual defects such as astigmatism and presbyopia by adding optical properties of cylinder and axis, which correct for irregularities in the shape of the cornea. CooperVision's in products are manufactured at its facilities located in Hampshire, United Kingdom, Juana Diaz, Puerto Rico, and West Henrietta, New York. It uses three different manufacturing processes to produce its lenses: lathing, cast molding and FIP(TM). CooperVision distributes products from West Henrietta, New York, Fareham, United Kingdom, Liege, Belgium, and other international distribution facilities. CooperSurgical focuses on supplying women's health clinicians with products and treatment options to improve the delivery of healthcare to women. CooperSurgical's offers products to aid clinicians in the management and treatment of commonly seen conditions. CooperSurgical customers are healthcare professionals and institutions providing care to and for women. CooperSurgical products support the point of healthcare delivery in the hospital, clinicians office and fertility clinics. CooperSurgical's manufacturing and distribution facilities are located in Trumbull, Connecticut, Malov, Denmark, Pasadena, California, Stafford, Texas, Golden, Colorado, and Berlin, Germany. The Company owns several manufacturing and research and development facilities, including 205,850 square feet in Hamble, United Kingdom, 49,500 square feet in Scottsville, New York, 63,787 square feet in Malov, Denmark, and 33,630 square feet in Stafford, Texas. The Company's products and medical devices are subject to extensive regulation by the United States Food and Drug Administration in the United States and other regulatory bodies abroad. The Company also owns certain trade secrets, copyrights, know-how and other intellectual property.
» More Articles for COO

Headlines

Articles On GuruFocus.com
Offsetters Helps Vancity Credit Union Achieve Carbon Neutrality for 6th Consecutive Year Dec 19 2014 
DENTSPLY´s Growth Opportunities Dec 16 2014 
Offsetters Climate Solutions Inc.: British Columbia Government Establishes New Regulated Carbon Offs Oct 23 2014 
Weekly CEO Sells Highlight: Cooper Companies, Broadcom Corp, Realpage Inc, and Freescale Semiconduct Jul 14 2014 
Baron Funds Comments on The Cooper Companies May 02 2014 
CR Bard Focuses on Small to Medium-Sized Deals Apr 04 2014 
Manning & Napier New Buys of Q1 Apr 19 2013 
The Cooper Companies: Not Eyeing It Yet Nov 27 2012 
The Cooper Companies Inc. (COO) CEO - CSI Nicholas J Pichotta sells 6,602 Shares Jan 11 2011 
The Cooper Companies Inc. (COO) CEO - CSI Nicholas J Pichotta sells 2,650 Shares Dec 13 2010 

More From Other Websites
COOPER COMPANIES INC Files SEC form 10-K, Annual Report Dec 19 2014
Coverage initiated on Cooper by Oppenheimer Dec 16 2014
Exclusive - Valeant to drop deal-making in near term to cut debt, boost stock Dec 09 2014
A surprisingly stronger than expected monthly payroll report... Dec 05 2014
The Cooper Companies Q4 Earnings, Revenues Lag; Up Y/Y Dec 05 2014
Ignore copper and mind the Swiss as jobs bring focus back to the U.S. Dec 05 2014
Gap shares rise on sales; Smith & Wesson slides on outlook Dec 04 2014
Updates, advisories and surprises Dec 04 2014
Cooper Companies Inc Earnings Call scheduled for 5:00 pm ET today Dec 04 2014
The Cooper Companies Misses Q4 Expectations Dec 04 2014
[$$] Cooper Lowers Profit Forecast Dec 04 2014
The Cooper Companies Announces Fourth Quarter and Full Year 2014 Results Dec 04 2014
Cooper Cos. shares fall on earnings, cut outlook Dec 04 2014
Cooper Cos. misses Street 4Q forecasts Dec 04 2014
Cooper Cos. misses Street 4Q forecasts Dec 04 2014
COOPER COMPANIES INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Dec 04 2014
The Cooper Companies Announces Fourth Quarter and Full Year 2014 Results Dec 04 2014
Q4 2014 Cooper Companies Inc Earnings Release - 4:00 pm ET Dec 04 2014
Cooper gets a vote of confidence Nov 28 2014
Cooper Companies (COO) Showing Signs Of Being Water-Logged And Getting Wetter Nov 10 2014

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK